SYRA · Syra Health Corp
$0.06
-0.05 (-47.12%)
At close · Apr 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 11, 2026
Market Cap
$10.79M
Shares
13.84M
Volume · Apr 21
920K
Avg daily vol (3M)
1.03M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.06
Open$0.07
Day$0.03–0.12
52W close$0.06–2.14
Avg vol 30d886K
Short int312K · 2.3% float · 8.5d
Short vol54%
Last earningsMay 8, 2025
DataSep 2023–Apr 2025
Filing10-Q · Aug 11
Up next
filed Aug 11, 2026
call held May 8, 2025
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$8.09M
Trailing 12 months
Net income (TTM)
$130,749
Trailing 12 months
Revenue growth YoY
+23.0%
Year over year
Operating margin
0.9%
Trailing 12 months
P / E (TTM)
5.5
Trailing earnings · reciprocal yield 18.2%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$2.12M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+13.5%
Year over year · more shares
Price change (1Y)
-94.7%
Trailing year
Short interest
—
Latest settlement
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bearish
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 17.3 · elevated
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−91%
below
Price vs 50-day avg
−83%
below
RSI (14)
20
oversold
MACD trend
Negative
52-week position
0%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−83%
trailing
6-month return
−86%
trailing
YTD return
−87%
this year
Relative strength
−75%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-80% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.26% of float · ▲ +103.7% MoM · 8.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
2 holders — near 2-yr low, contrarian setup
Fundamentals
Revenue growth
−9%
Y/Y
Gross margin
34%
expanding
EPS growth
+84%
Y/Y
Free cash flow
$-447.9K
Valuation
P/E 78
rich
Quant / Vol
risk profile
Volatility
152%
annualized · 1-yr
Max drawdown
−97%
past year
ATR
88.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−91%
Bearish
Price vs 50-day avg
−83%
Bearish
RSI (14)
20
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-80% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
2.26% of float · ▲ +103.7% MoM · 8.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr low
2 holders — near 2-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0
Now $0 · 0%
Range high $2
vs 200-day avg -91%
vs 50-day avg -83%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $253,200 | Three Months Ended June 30, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Net Income (Loss) $250,242
+$2,217 Interest expense
+$741 Depreciation expense
+$0 Taxes
= Adjusted EBITDA $253,200
|
|||
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SYRA
this stock
Syra Health Corp
|
$10.79M | — | -9.5% | 78.0 | 2.3% |
|
HCA
HCA Healthcare, Inc.
|
$103.32B | -0.2% | +7.1% | 15.6 | 2.2% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$28.30B | -12.4% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.45B | +37.0% | +0.9% | 10.3 | 2.3% |
|
EHC
Encompass Health Corp
|
$12.00B | +14.6% | +10.5% | 19.8 | 3.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
2
- % held
- 1.2%
- Net QoQ
- +3.9K sh
- Top holder
- JANE STREET GROUP, LLC
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SYRA | -72.6% | -83.1% | -86.4% | -78.9% | -86.7% |
| SPY | -3.8% | -8.9% | -11.3% | -8.1% | -12.3% |
| vs SPY | -68.9% | -74.2% | -75.1% | -70.7% | -74.3% |